Our in vitro biology expertise for advancing your drug discovery programs
Welcome To BIOMEDHA
BioMedha is a UK-based pre-clinical CRO providing in vitro biology drug discovery expertise to the global drug discovery industry. We are industry-experienced, in vitro biology-focused scientists and can add significant value to our client programmes by undertaking key elements of the early stage drug discovery process, such as:
- Immuno-modulation studies (whole blood, PBMC, monocytes, T-cell, neutrophils, B cells, dendritic cells, and macrophages)
- Expression studies (protein levels and mRNA levels)
- Functional Studies (Receptor, pathway signalling, bioassays)
- Cytokine assays and Immunogenicity assessment (Multiplexing)
- Mitochondrial function and toxicity assessment
- Drug combination studies
- Cell health assays (Oncology)
- GPCRs: Assay development and screening
- Biochemical assays
